PT - JOURNAL ARTICLE AU - Eliaz, Yossi AU - Danovich, Mark AU - Gasic, Gregory P. TI - Poolkeh Finds the Optimal Pooling Strategy for a Population-wide COVID-19 Testing (Israel, UK, and US as Test Cases) AID - 10.1101/2020.04.25.20079343 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.25.20079343 4099 - http://medrxiv.org/content/early/2020/05/05/2020.04.25.20079343.short 4100 - http://medrxiv.org/content/early/2020/05/05/2020.04.25.20079343.full AB - The SARS-CoV-2 pandemic has changed the lifestyle of citizens of the world. In order for decision makers to manage the viral spread of COVID-19 both in the intra-national and the international frontiers, it is essential to operate based on data-driven assessments. It’s crucial to do so rapidly and frequently, since the nature of the viral spread grows exponentially and can burst worldwide again. A fast and accurate health status of individuals globally during a pandemic can save many lives and bring life back to a new normal. Herein, we present a data-driven tool to allow decision-makers to assess the spread of the virus among the world population. Our framework allows health agencies to maximize the throughput of COVID-19 tests among the world population by finding the best test pooling that fits the current SIR-D [1] status of the nation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe would like to thank the national institute of science (NSF) for the funding resources, the University of Houston, and the Center for Theoretical Biological Physics (CTBP) at Rice University. We also want to express our gratitude for the computation resources from Google, Heroku, and Netlify.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data and tools that support the findings of this study are openly available in http://poolkeh.github.io/ and https://poolkeh.herokuapp.com/. https://poolkeh.herokuapp.com/ http://poolkeh.github.io/